Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

3.58
+0.10503.03%
Volume:206.71K
Turnover:738.38K
Market Cap:305.95M
PE:-2.17
High:3.62
Open:3.50
Low:3.50
Close:3.47
Loading ...
Nov 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 22, 2023

Major Issues Report

Form 8-K - Current report
May 22, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2022

Major Issues Report

8-K - Current report